Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-20 in severe COVID-19 pneumonia
NCT04398303Phase 2Unknown
- Sponsor
- Aspire Health Science
- Start
- May 2020
- Primary completion
- Oct 2020
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of ACT-20-MSC, ACT-20-CM in COVID-19 pneumonia, sponsored by Aspire Health Science. Status: unknown.
02
Drugs
ACT-20-MSCACT-20-CM
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04398303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04398303.